EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola survivors get vaccine boost in landmark study
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether giving the Ebola vaccine (ERVEBO®) to people who have already survived Ebola can strengthen their immune system and provide longer protection. Researchers will compare 20 survivors with 20 people who never had Ebola, all receiving one vaccine dose. The…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE4 • Sponsor: Tulane University • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:54 UTC
-
Lifeline offered for ebola patients in outbreak zones
Disease control AVAILABLEThis program provides emergency access to an experimental antibody treatment (REGN-EB3) for people sick with Ebola virus disease in outbreak regions. It is for patients who are not eligible for or cannot join the main clinical trials. The goal is to control the viral infection an…
Matched conditions: EBOLA VIRUS DISEASE
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:41 UTC